Between 30 April and 5 May 2016, the National IHR Focal Point for the Kingdom of Saudi Arabia notified WHO of 4 additional cases of Middle East Respiratory Syndrome (MERS-CoV), including one fatal case.
Details of the cases
A 39-year-old, non-national, male living in Riyadh city is a household contact of another MERS-CoV (see case no. 2 below). He is asymptomatic and identified through tracing of contacts. The patient, who has no comorbid conditions, tested positive for MERS-CoV on 5 May. The patient is currently in home isolation.
Diagnosing malaria may soon be as easy taking a simple breath test, according to researchers.
“We really envision this working just like a breathalyzer test when you get pulled over for drunk driving,” said Dr. Audrey Odom, an assistant professor of pediatrics and molecular biology at Washington University in St. Louis.
As the quest for a Zika vaccine unfolds, Inovio Pharma ($INO) continues to lead the pack. The Pennsylvania-based vaccine maker announced Monday that its candidate showed promise in nonhuman primates.
The company’s synthetic DNA vaccine elicited “robust” antibody and T cell responses in monkeys, Inovio said in a statement. Each animal that received two doses of the vaccine developed antibodies against the mosquito-borne disease. Three months ago, Inovio reported that the candidate performed well in mice.
A new report released by the United Nations Secretary-General, Ban Ki-moon, warns that the AIDS epidemic could be prolonged indefinitely if urgent action is not implemented within the next five years. The report, On the Fast-Track to end the AIDS epidemic, reveals that the extraordinary acceleration of progress made over the past 15 years could be lost and urges all partners to concentrate their efforts to increase and front-load investments to ensure that the global AIDS epidemic is ended as a public health threat by 2030.
The introduction of three new antiretroviral medicines for treating people with HIV could save $3 billion for programmes in low- and middle-income countries by the end of 2025. This finding was presented in February at the world's premier HIV science meeting: the Conference on Retroviruses and Opportunistic Infections, better known as CROI.
Dr Doussou Touré arrives for work at Coléah Medical Centre. She washes her hands from a bucket set up in front of the building, proceeds to a screening area where her temperature is checked and recorded and only then enters the bustling facility that she supervises.
“Ebola is under control now, but we try to keep up the infection prevention and control systems that were put in place during the outbreak,” Dr Touré says, pointing to several sturdy, brightly-coloured bins, each one designated for the disposal of varying waste matter.